A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
Pierangela SepeGiuseppe ProcopioChiara Carlotta PircherUmberto BassoOrazio CaffoVera CappellettiMelanie ClapsUgo De GiorgiLucia FratinoValentina GuadalupiPatrizia MiodiniCinzia De MarcoBruno PerrucciAlessia MennittoDaniele SantiniFrancesco SpinaMarco StellatoFilippo de BraudElena VerzoniPublished in: Therapeutic advances in medical oncology (2024)
ClinicalTrials.gov Identifier: NCT03103724. First Posted: 6 April 2017. First patient enrollment: 19 April 2017.